Daily News Podcast

Antibody cleared amyloid plaques, slowed cognitive decline

Publish date: July 27, 2018

 

An experimental agent slowed cognitive decline and cleared Alzheimer’s plaques. Can meteorology predict migraines? Why closing a patent foramen ovale is the right approach to prevent recurring ischemic stroke. And claims that cannabis relieves noncancer pain go up in smoke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

VIDEO: Pills alone not the answer for pain management
MDedge Rheumatology
NIH launches HEAL Initiative to combat opioid crisis
MDedge Rheumatology
Do free meals to physicians affect opioid prescribing?
MDedge Rheumatology
Data suggest harm outweighs benefit of opioids for musculoskeletal pain
MDedge Rheumatology
CDC releases website for ME/CFS information
MDedge Rheumatology
Fentanyl analogs nearly double their overdose death toll
MDedge Rheumatology
Malpractice and pain management
MDedge Rheumatology
Is fibromyalgia one disorder – or two?
MDedge Rheumatology
Is fish oil’s heart benefit a fish tale?
MDedge Rheumatology
Blood pressure meds cut cognitive impairment risk
MDedge Rheumatology